(Q35089930)

6 August 2017

Aloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer study (English)

1 reference

6 August 2017

0 references

Ruie Chen

1

1 reference

6 August 2017

Shengpeng Wang

2

1 reference

6 August 2017

Jinming Zhang

3

1 reference

6 August 2017

Meiwan Chen

4

1 reference

6 August 2017

Yitao Wang

5

1 reference

6 August 2017

language of work or name

English

0 references

publication date

11 February 2014

1 reference

6 August 2017

1 reference

6 August 2017

22

1 reference

6 August 2017

5

1 reference

6 August 2017

666-674

1 reference

Solid lipid nanoparticles as a drug delivery system for peptides and proteins

6 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

Aloe-emodin induced in vitro G2/M arrest of cell cycle in human promyelocytic leukemia HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

Aloe-emodin-induced apoptosis in human gastric carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

The molecular effects of aloe-emodin (AE)/liposome-AE on human nonmelanoma skin cancer cells and skin permeation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

Anticancer potential of aloes: antioxidant, antiproliferative, and immunostimulatory attributes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

Apoptosis: biochemical aspects and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

Physicochemical characterization of curcuminoid-loaded solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

Absorption, pharmacokinetics and disposition properties of solid lipid nanoparticles (SLNs).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.882446

10.3109/10717544.2014.882446

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference